Detalhe da pesquisa
1.
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset.
Am J Respir Crit Care Med
; 209(7): 840-851, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226855
2.
Best practices: Appropriate use of the new ß-lactam/ß-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa.
S Afr J Infect Dis
; 37(1): 453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36338193